Solid Biosciences Outpaces Competitors In Duchenne Gene Therapy Development (CORRECTED)
Editor’s Note: This article has been corrected to reflect that Truist initiated coverage of Solid Biosciences on Wednesday. On Wednesday, Truist initiated coverage on Solid Biosciences Inc. SLDB, a clinical-stage biotech developing gene therapies for …